@article{8eede361eef44ba995132c6a5adc7987,
title = "Rituximab and intravenous immune globulin for desensitization during renal transplantation",
keywords = "Graft Rejection/epidemiology, Antibodies, Monoclonal, Murine-Derived, Antibodies/blood, Humans, Middle Aged, Antigens, CD19/blood, Rituximab, Immunoglobulins, Intravenous/adverse effects, Male, Survival Rate, Creatinine/blood, Desensitization, Immunologic/methods, Antibodies, Monoclonal/adverse effects, Immunologic Factors/adverse effects, Kidney Transplantation/immunology, Antigens, CD20/immunology, Adult, Female, Drug Therapy, Combination, HLA Antigens/immunology, Immunosuppression Therapy/methods",
author = "Vo, \{Ashley A.\} and Marina Lukovsky and Mieko Toyoda and Jennifer Wang and Reinsmoen, \{Nancy L.\} and Lai, \{Chih Hung\} and Alice Peng and Rafael Villicana and Jordan, \{Stanley C.\}",
note = "2008 Massachusetts Medical Society",
year = "2008",
month = jul,
day = "17",
doi = "10.1056/NEJMoa0707894",
language = "English",
volume = "359",
pages = "242--251",
journal = "New England Journal of Medicine",
issn = "0028-4793",
number = "3",
}